Zobrazeno 1 - 10 of 42 pro vyhledávání: '"Brett Pinsky"'
1
Hypothyroidism Prevalence in the United States: A Retrospective Study Combining National Health and Nutrition Examination Survey and Claims Data, 2009–2019
Autor: Kathleen L Wyne, Lekshmi Nair, Chris P Schneiderman, Brett Pinsky, Oscar Antunez Flores, Dianlin Guo, Bruce Barger, Alexander H Tessnow
Publikováno v: Journal of the Endocrine Society. 7
Previous estimates determined prevalence of hypothyroidism (HT) to be 4.6% of the US population. This study aimed to update estimates of HT prevalence in the United States by retrospective analysis of 2 datasets. Data on HT type (overt or subclinical
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2d0063d00db2b73c47326e6029179d2
https://doi.org/10.1210/jendso/bvac172
Zobrazit plný text záznamu
5
Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus Infections
Autor: Eric Q. Wu, Tania M. Welzel, Yanjun Bao, Yaozhu J. Chen, Brett Pinsky, Douglas T. Dieterich, Gautam Sajeev, Min Yang
Publikováno v: Advances in Therapy
Introduction The new direct acting antiviral (DAA) therapies are able to effectively treat chronic hepatitis C (CHC). This study elicited the preferences of CHC patients for treatment attributes of new DAAs. Methods An online discrete choice experime
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76f1f5ca14f016a565e7d656554a6afa
https://doi.org/10.1007/s12325-019-01012-6
Zobrazit plný text záznamu
6
Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis
Autor: Francesco Negro, Pamela S. Belperio, Andrew H. Talal, Mark Bondin, Federico J. Mensa, Caroline Park, David Back, Brett Pinsky, Eric Crown, Fiona Marra, Zhenzhen Zhang
Publikováno v: Journal of Viral Hepatitis
JOURNAL OF VIRAL HEPATITIS
Journal of Viral Hepatitis, Vol. 26, No 8 (2019) pp. 951-960
Although direct‐acting antivirals (DAAs) for chronic hepatitis C virus (HCV) infection are highly efficacious and safe, treatment initiation is often limited in patients with neuropsychiatric disorders due to concerns over reduced treatment adheren
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22d834b8e5978f4925c02a4f8c34e7f8
https://doi.org/10.1111/jvh.13110
Zobrazit plný text záznamu
7
Effect of ombitasvir/paritaprevir/ritonavir + dasabuvir regimen on health-related quality of life for patients with hepatitis C
Autor: Brett Pinsky, Stacie Hudgens, D. Mehta, Yanjun Bao, Sammy Saab, Nathan Grunow
Publikováno v: Liver International. 38:1377-1394
Background & aims This study analyses health-related quality of life data from 8 randomized clinical trials using ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin to investigate: (i) the impact of the treatment vs placebo during treatment
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b280dbc11048a505027e0081365ed3f7
https://doi.org/10.1111/liv.13690
Zobrazit plný text záznamu
8
Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real-world data from a large healthcare provider
Autor: Varda Shalev, J. C. Samp, G. Chodick, G. Koren, Clara Weil, D. Mehta, Brett Pinsky
Publikováno v: Journal of Viral Hepatitis. 25:144-151
Treatment with ombitasvir/paritaprevir/ritonavir and dasabuvir, with or without ribavirin (OPrD ± RBV), was the first interferon-free direct-acting antiviral for hepatitis C virus (HCV) introduced to Israel's national basket of health services in Fe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c65ab882393707c32471c4f075822ff7
https://doi.org/10.1111/jvh.12800
Zobrazit plný text záznamu
9
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Autor: David A. Williams, Kim A. Papp, Alexa B. Kimball, Alice B. Gottlieb, Brett Pinsky, Dawn M. Carlson, Francisco A. Kerdel, Errol-Prospero Prens, Neil J. Korman, Charles Lynde, Murali Sundaram, Nael M. Mostafa, Ziad Reguiai, Martin M. Okun, Seth B Forman, Yihua Gu, Eihab Alwawi, April W. Armstrong, Jeffrey J. Crowley, Christos C. Zouboulis, Gregor B.E. Jemec, Evangelos J. Giamarellos-Bourboulis, Michael H. Gold
Publikováno v: New England Journal of Medicine, 375(5), 422-434. Massachussetts Medical Society
Hidradenitis suppurativa is a painful, chronic inflammatory skin disease with few options for effective treatment. In a phase 2 trial, adalimumab, an antibody against tumor necrosis factor α, showed efficacy against hidradenitis suppurativa.PIONEER
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8aec9dd6c19a6a368c80407469994d4
https://pure.eur.nl/en/publications/36ae65ea-a400-4cfd-b5dc-df8aa831ce58
Zobrazit plný text záznamu
10
Cost-Effectiveness Analysis of Atorvastatin versus Rosuvastatin in Primary and Secondary Cardiovascular Prevention Populations in Brazil and Columbia
Autor: Brett Pinsky, Jaime Eduardo Ordóñez Molina, Nicolás Vargas Zea, Magda Vianey Gutiérrez-Ardila, Joaquin Mould-Quevedo
Publikováno v: Value in Health Regional Issues. 5:48-57
Background: Latin America has witnessed a marked increase in cardiovascular (CV) disease, the leading cause of death in many countries. The benefits of lipid-lowering therapy to reduce CVrelated events are widely accepted. Clinical evidence suggests
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e53776c66b3f4339b682bdec3af3f1a6
https://doi.org/10.1016/j.vhri.2014.07.007
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje